Biotechnology, Diagnostics, and Genomics: Panel Discussion

Posted: September 24, 2011 at 10:32 am

This post was added by Dr. Richardson


Rob Chess, Chairman of Nektar Therapeutics, led this interactive panel discussion on biotechnology, diagnostics, and genomics. Panelists included Don Joseph of BIO Ventures for Global Health, David Levison of CardioDX, Bala Manian, a serial entrepreneur, and James Sabry of Genentech.

Go here to read the rest:
Biotechnology, Diagnostics, and Genomics: Panel Discussion

Related Post
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.